PB&B SA

• PB&B’s novel injectable technology allows plastic surgeons and dermatologists to enhance fat tissue volume with lipids to naturally remodel facial and body areas.
• Patent granted to date in 13 countries (USA, China,…) with all claims and applications. Full FTO (Freedom-to-Operate).
• Developed by an international team of plastic surgeons and bioengineers. Technology entering clinical testing phase towards an approval in Europe, US, and China in 2025.
• PB&B has won numerous innovation and startup awards, including the IMCAS Innovation of the Year award 2018 (largest global medical aesthetics congress – Paris, France).
• 3 Innovation government grants (CH, EU, CN) approved based on innovation & market potential.
• PB&B Funding to date: 7 MUSD